These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer]. Yuan SQ, Zhou ZW, Liang YJ, Fu LW, Chen G, Keshari RP, Zhang LY. Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290 [Abstract] [Full Text] [Related]
24. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA. Gao P, Zhou GY, Zhang QH, Li H, Mu K, Yuan YP, Zhang J, Wang BH. Chin J Physiol; 2006 Apr 30; 49(2):96-103. PubMed ID: 16830791 [Abstract] [Full Text] [Related]
25. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J, Fang X, Hao J, Sha X. Biomaterials; 2015 Mar 30; 45():99-114. PubMed ID: 25662500 [Abstract] [Full Text] [Related]
26. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer. Hegewisch-Becker S, Staib F, Löning T, Pichlmeier U, Kröger N, Reymann A, Hossfeld DK. Ann Oncol; 1998 Jan 30; 9(1):85-93. PubMed ID: 9541688 [Abstract] [Full Text] [Related]
27. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. Chaudhary PM, Roninson IB. J Natl Cancer Inst; 1993 Apr 21; 85(8):632-9. PubMed ID: 8096875 [Abstract] [Full Text] [Related]
28. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas. Lacave R, Coulet F, Ricci S, Touboul E, Flahault A, Rateau JG, Cesari D, Lefranc JP, Bernaudin JF. Br J Cancer; 1998 Mar 21; 77(5):694-702. PubMed ID: 9514046 [Abstract] [Full Text] [Related]
29. Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNA. Chan JY, Chu AC, Fung KP. Life Sci; 2000 Sep 15; 67(17):2117-24. PubMed ID: 11057761 [Abstract] [Full Text] [Related]
30. Spontaneous reversal of p-glycoprotein expression in multidrug resistant cell lines. Gréen H, Lotfi K, Zackrisson AL, Peterson C. Pharmacol Toxicol; 2003 Dec 15; 93(6):297-304. PubMed ID: 14675464 [Abstract] [Full Text] [Related]
31. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW, Wu X, Yin C, Chai S, Yao S, Kadioglu O, Efferth T, Ye Y, Lin G. J Ethnopharmacol; 2017 May 05; 203():110-119. PubMed ID: 28363522 [Abstract] [Full Text] [Related]
32. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas. Hoffmann J, Schmidt-Peter P, Hänsch W, Naundorf H, Bunge A, Becker M, Fichtner I. Clin Cancer Res; 1999 Aug 05; 5(8):2198-204. PubMed ID: 10473106 [Abstract] [Full Text] [Related]
33. Transcriptional regulation of multidrug resistance in breast cancer. Glazer RI, Rohlff C. Breast Cancer Res Treat; 1994 Aug 05; 31(2-3):263-71. PubMed ID: 7881104 [Abstract] [Full Text] [Related]
34. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440). Hofmann J, Utz I, Spitaler M, Hofer S, Rybczynska M, Beck WT, Herrmann DB, Grunicke H. Br J Cancer; 1997 Aug 05; 76(7):862-9. PubMed ID: 9328144 [Abstract] [Full Text] [Related]
35. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. Kitazono M, Sumizawa T, Takebayashi Y, Chen ZS, Furukawa T, Nagayama S, Tani A, Takao S, Aikou T, Akiyama S. J Natl Cancer Inst; 1999 Oct 06; 91(19):1647-53. PubMed ID: 10511592 [Abstract] [Full Text] [Related]
36. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z, Yang N, Liang W, Yan X, Li L, Pan L. Leuk Lymphoma; 2012 Jul 06; 53(7):1383-9. PubMed ID: 22185283 [Abstract] [Full Text] [Related]
37. New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene. Mickisch GH, Merlino GT, Aiken PM, Gottesman MM, Pastan I. J Urol; 1991 Aug 06; 146(2):447-53. PubMed ID: 1677434 [Abstract] [Full Text] [Related]
38. Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176). Robey RW, Zhan Z, Piekarz RL, Kayastha GL, Fojo T, Bates SE. Clin Cancer Res; 2006 Mar 01; 12(5):1547-55. PubMed ID: 16533780 [Abstract] [Full Text] [Related]
39. P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. Abe Y, Ohnishi Y, Yoshimura M, Ota E, Ozeki Y, Oshika Y, Tokunaga T, Yamazaki H, Ueyema Y, Ogata T, Tamaoki N, Nakamura M. Br J Cancer; 1996 Dec 01; 74(12):1929-34. PubMed ID: 8980392 [Abstract] [Full Text] [Related]
40. Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma. Chen KG, Lacayo NJ, Durán GE, Wang Y, Bangs CD, Rea S, Kovacs M, Cherry AM, Brown JM, Sikic BI. Genes Chromosomes Cancer; 2002 Aug 01; 34(4):372-83. PubMed ID: 12112526 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]